Investment

Synlab Management, Supervisory Boards Remain Neutral on Cinven Offer

1 Mins read

By Helena Smolak


Synlab’s management and supervisory boards remain neutral on whether to accept or decline a takeover offer of 2.22 billion euros ($2.36 billion) made by Cinven.

The German medical-diagnostic company said late Thursday that its management and supervisory boards don’t consider the EUR10 a share price offered by the U.K. private-equity firm to reflect its long-term value, but see the proposal as a potentially attractive exit opportunity for short-term oriented or risk-averse investors.

However, the boards view positively Cinven’s support for Synlab’s long-term strategy, the company said.

The joint statement from Synlab’s boards came after what the company called a thorough evaluation of the offer, but was in line with their initial assessment when the bid was disclosed on Sept. 29.

Cinven first expressed interest in taking full ownership of the company’s shares in March, already holding 43% of Synlab’s share capital.

The acceptance period for the offer started Oct. 23 and remains open until Nov. 20, Synlab said.


Write to Helena Smolak at [email protected]


Read the full article here

Related posts
Investment

Is Magnificent 7 Momentum Setting Investors Up for Disappointment?

1 Mins read
The Magnificent Seven stocks have experienced remarkable earnings and free-cash-flow growth in recent years, all while developing the next generation of technological…
Investment

This fund manager stopped worrying about economics. Now he is outperforming the stock market.

4 Mins read
A change in strategy has helped transform the GoodHaven Fund from a long-term underperformer into an outperformer since the end of 2019….
Investment

After 34 years, Japan’s Nikkei 225 completes a roundtrip

2 Mins read
The Nikkei 225 — an oddly constructed index covering the top 225 Japanese companies — is back at levels not reached since…
Get The Latest News

Subscribe to get the top fintech and
finance news and updates.

Leave a Reply

Your email address will not be published. Required fields are marked *